Marker Therapeutics Inc (MRKR)

[hyperopia]

It’s true. Piper Jaffray initiated coverage and put out a research note on Monday. (price was ~$8.50 at the time)

https://thefly.com/landingPageNews.php?id=2807625&headline=MRKR-Marker-Therapeutics-initiated-

Marker Therapeutics initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff started Marker Therapeutics with a Neutral rating and $10 price target. The analyst believes the company's Multi Tumor-Associated Antigen Cell Therapy platform "offers several key advantages over current autologous CAR-T including improved manufacturing time and expense, and potentially safer, more durable response."

I actually think if Marker had gone the IPO route, they probably would have been valued at least double that, but this seems reasonable to me and is close to the comparative valuation that Nomura provided in the merger agreement (fully diluted). And actually, if you watched the merger presentation with Peter, he provides the same valuation and says: “If someone offers you half of their 600 or 800 million dollars in return for half of your 30 or 40 million, that is a transaction that is going to yield a tremendous amount of value for you.” This was exactly my thinking as well, and I believe (especially at today’s price) there is still value here. I put my other leg in and bought more this morning.